Gilenya Shows Long-term Efficacy, Safety in Real-world RRMS Study
Long-term treatment with Gilenya (fingolimod) in routine clinical practice is safe and effective for relapsing-remitting multiple sclerosis (RRMS),…
Articles by Margarida Maia, PhD
Cognition-targeted Exercise May Boost CBT’s Easing of Fatigue
Cognition-targeting exercise, when combined with cognitive behavioral therapy (CBT) — a type of talk therapy — may further ease fatigue…
Donations to MS Society of Canada Triple in Value Through Dec. 31
Donations to the Multiple Sclerosis Society of Canada through the end of this year will be double matched, meaning…
Higher Genetic Risk for MS Linked to Disease Onset at Younger Ages
People with a higher genetic risk for multiple sclerosis (MS) are significantly more likely to develop the disease at…
Cortrophin Gel Now Available in US at AllianceRx Walgreens Prime
Cortrophin Gel (repository corticotropin injection), an injectable gel medication approved for acute flares in multiple sclerosis (MS) and…
Sensorimotor Exercise Linked to Better Overall Quality of Life
Sensorimotor exercise, which aims to improve the neuromuscular system with reduced pressure interventions, such as robotic-assisted training or aquatic exercises,…
OTC Melatonin Improves Sleep Quality in MS Patients, Trial Finds
Taking the hormone melatonin may increase overall sleep quality in people with multiple sclerosis (MS), a clinical trial found.
Mynd Tests MAP, Blood Biomarker for MS Diagnosis
Mynd Diagnostics is launching a clinical study to test the ability of a blood biomarker, which the company coined Mynd…
COVID-19 Vaccine Side Effects With MS Similar to Public at Large
Side effects upon receiving the COVID-19 vaccine in people with multiple sclerosis (MS) are similar to those reported in the…
Analysis Finds Acthar Gel Cost-effective for MS Relapses
Acthar Gel (repository corticotropin injection) was found to be a cost-effective treatment for people with multiple sclerosis (MS)…
Owlytics’ MS Smartwatch Goes Through First Validation Stage
Owlytics Healthcare, in partnership with Tel-Aviv Medical Center in Israel, has taken its smartwatch — designed to monitor symptoms…
Australian Council Supports Research Into MS Risk Factors, Falls
Australia’s National Health and Medical Research Council (NHMRC) is giving a total of AU$6.75 million (about $5 million) in…
Having MS Did Not Increase Risk of Severe COVID-19 in German Study
People with multiple sclerosis (MS) are not at greater risk for severe COVID-19 outcomes, according to a study of…
Vibration Training Also Seen to Aid Cognition and Life Quality in Study
A six-week program, called vibration training — in which people stand on a vibrating platform for short periods of time…
MS Society to Hold Black MS Experience Summit
The National Multiple Sclerosis Society will host the second edition of its Black MS Experience Summit, a…
Barriers Limit Sativex Access for Patients With Spasticity in UK
Sativex (nabiximols), a cannabis-based oral spray approved in the U.K. to ease spasticity — or muscle stiffness and…
Brain Structures Tied to Worse Memory in Pediatric-onset MS
People who develop multiple sclerosis (MS) in childhood have more difficulty recognizing words and faces than healthy individuals, a…
Skin Reactions ‘Frequent’ With Mavenclad, Real-world Study Finds
Skin reactions are common among relapsing-remitting multiple sclerosis (RRMS) patients being treated with oral Mavenclad (cladribine), affecting about one-third…
US Study: Black Patients Have More Severe Disease Than Whites
Blacks with multiple sclerosis (MS) have more severe disease and greater disability at their first visit than white patients,…
UCL Neurologist Wins 2021 Charcot Award for Efforts in MS Research
Alan Thompson, dean of the Faculty of Brain Sciences at University College London (UCL), has won the 2021Â Charcot Award,…
Abata Opens With Plans to Develop T-cell Therapies for Progressive MS
Abata Therapeutics has opened with $95 million in financing, and plans to use regulatory T-cells to treat autoimmune…
Stopping Cannabis Aids Cognition in MS, But Not Awareness of Gains
People with multiple sclerosis (MS) may not be entirely aware of the decline in their cognitive abilities with cannabis…
Medical Cannabis in Greece Will Be Sold Under Brand Name Panaxir
Medical cannabis made by Panaxia Labs Israel will be marketed and distributed in Greece by Leriva Group, under…
Impaired Social Cognition May Affect Well-being of RRMS Patients
Impaired social cognition — lacking the ability to understand and process others’ emotions — may affect how people with…
AstraZeneca’s COVID-19 Vaccine Safe for MS Patients, Small Study Suggests
AstraZeneca’s COVID-19 vaccine appears to be reasonably safe for people with multiple sclerosis (MS), according to a small…
MS Patients May Apply for Mental Health, Addiction Treatment Scholarship
The Red Songbird Foundation welcomes people with multiple sclerosis (MS) who are struggling with issues relating to mental health or…
PicnicHealth, Komodo Pool Real-world Data for Research
PicnicHealth and Komodo Health have agreed to combine their databases of patient medical records to support research based…
US Patent Issued for Software That Could Make MRI Scans Safer
Subtle Medical announced the granting of a U.S. patent for its radiology software that uses artificial intelligence to improve the…
Repertoire, Yale Working to Identify T-cells Driving MS
Repertoire Immune Medicines and Yale University have entered a research collaboration to identify what type of antigens are…
Helper T-cells Drive Transition from RRMS to SPMS, Study Suggests
A group of helper T-cell (Th cells), a type of immune cell, could be responsible for the transition from…